D.Western Therapeutics Institute, Inc.JP:4576
| Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Profit (loss) before income taxes | -255 | -221 | -192 | -295 | -304 | -1,606 | -802 | 110 | -290 | -160 | -440 | -827 |
|---|
| Depreciation | 3 | 2 | 2 | 3 | 18 | 45 | 52 | 44 | 44 | 45 | 46 | 49 |
|---|
| Impairment losses | - | - | - | - | - | 1,040 | 7 | - | - | - | - | 6 |
|---|
| Increase (decrease) in allowance for doubtful accounts | - | - | - | - | 6 | - | - | - | - | - | - | 11 |
|---|
| Share-based payment expenses | - | - | - | - | - | - | 6 | 3 | 10 | 15 | 16 | 16 |
|---|
| Settlement money | - | - | - | - | - | - | - | - | - | - | 44 | - |
|---|
| Interest income | -0 | -1 | -1 | -4 | -3 | -1 | -0 | -0 | -0 | -0 | -0 | -0 |
|---|
| Interest expenses | - | - | - | - | - | 5 | 6 | 6 | 5 | 4 | 3 | 2 |
|---|
| Commission expenses | - | - | - | - | - | 18 | - | - | - | - | 14 | 0 |
|---|
| Foreign exchange losses (gains) | -0 | -0 | -2 | -0 | -22 | 6 | 1 | -1 | 7 | -18 | -30 | -1 |
|---|
| Share issuance costs | 1 | 8 | 0 | 0 | 4 | - | - | - | 4 | 1 | 1 | 1 |
|---|
| Share issuance costs | - | - | - | - | - | - | - | - | 6 | - | 11 | - |
|---|
| Loss (gain) on valuation of investment securities | - | - | - | - | - | - | - | - | - | - | 100 | 13 |
|---|
| Decrease (increase) in trade receivables | - | - | -0 | -23 | -18 | -20 | -10 | -33 | 12 | -10 | -113 | 54 |
|---|
| Decrease (increase) in inventories | 1 | 0 | -4 | 0 | -54 | 11 | -13 | 0 | 1 | -30 | 9 | 23 |
|---|
| Increase (decrease) in accounts payable - other | -9 | 3 | -1 | 2 | -2 | 19 | 2 | -5 | 12 | 4 | 22 | 95 |
|---|
| Other, net | -5 | 2 | -0 | 3 | 44 | -207 | 220 | 59 | -21 | -23 | -34 | -26 |
|---|
| Subtotal | -264 | -199 | -226 | -325 | -336 | -792 | -533 | 183 | -210 | -171 | -350 | -583 |
|---|
| Interest and dividends received | - | - | - | 4 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Interest paid | - | - | - | - | - | -7 | -6 | -6 | -4 | -4 | -3 | -2 |
|---|
| Income taxes paid | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -2 | -2 | -2 | -2 | -2 |
|---|
| Net cash provided by (used in) operating activities | -264 | -200 | -224 | -323 | -334 | -797 | -540 | 176 | -216 | -176 | -355 | -587 |
|---|
| Purchase of property, plant and equipment | -1 | -2 | -3 | -1 | -37 | -4 | -6 | - | -5 | -2 | -10 | -12 |
|---|
| Purchase of intangible assets | - | -0 | - | -2 | -0 | -0 | -5 | - | -0 | -1 | -0 | -3 |
|---|
| Purchase of investment securities | - | - | -10 | -100 | - | - | - | - | -8 | -109 | -130 | - |
|---|
| Decrease (increase) in guarantee deposits | - | - | - | - | - | - | - | - | -0 | 1 | 0 | -0 |
|---|
| Net cash provided by (used in) investing activities | 99 | -1,003 | 287 | 835 | -231 | -763 | -8 | -100 | -13 | -111 | -140 | -15 |
|---|
| Proceeds from long-term borrowings | - | - | - | - | - | 582 | - | - | 100 | - | 13 | 166 |
|---|
| Repayments of long-term borrowings | - | - | - | - | - | - | - | -120 | -120 | -120 | -120 | -120 |
|---|
| Proceeds from issuance of convertible bonds with subscription rights to shares | - | - | - | - | - | - | - | - | - | - | 900 | - |
|---|
| Proceeds from issuance of share acquisition rights | - | 32 | - | 22 | - | - | - | - | 1 | - | 1 | - |
|---|
| Proceeds from issuance of shares resulting from exercise of share acquisition rights | 69 | 1,995 | 37 | 66 | 1,071 | 825 | - | - | 1,023 | 17 | 100 | 89 |
|---|
| Payments for issuance of shares | - | - | - | - | - | - | - | - | - | -1 | -11 | - |
|---|
| Purchase of treasury shares | - | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Purchase of treasury share acquisition rights | - | - | - | - | - | - | - | - | - | - | -3 | - |
|---|
| Commission expenses paid | - | - | - | - | - | - | - | - | - | - | -13 | -1 |
|---|
| Other, net | - | - | - | - | - | - | - | - | - | - | -0 | - |
|---|
| Net cash provided by (used in) financing activities | 69 | 2,026 | 37 | 88 | 1,067 | 1,407 | - | -120 | 1,004 | -104 | 867 | 134 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 0 | 0 | 0 | - | 23 | -6 | -0 | 1 | -7 | 17 | 28 | 0 |
|---|
| Net increase (decrease) in cash and cash equivalents | -96 | 823 | 100 | 600 | 525 | -159 | -548 | -43 | 767 | -374 | 401 | -467 |
|---|